08:00 , Jan 13, 2014 |  BC Week In Review  |  Company News

Enzo, Life Technologies genomics news

A federal judge in the U.S. District Court for the District of Connecticut awarded Enzo prejudgment interest of $12.4 million, bringing Enzo's total award to $61 million from a patent infringement suit against Life Technologies....
07:00 , Aug 19, 2013 |  BC Week In Review  |  Company News

Enzo, Life Technologies genomics news

A federal judge in the U.S. District Court for the District of Connecticut upheld a November jury verdict that awarded Enzo $48.6 million in direct patent infringement penalties in a suit against Life Technologies. The...
08:00 , Nov 5, 2012 |  BC Week In Review  |  Company News

Enzo, Life Technologies genomics news

A jury in the U.S. District Court for the District of Connecticut awarded Enzo $48.6 million in penalties in a patent infringement suit against Life Technologies. Enzo was also awarded pre-judgment interest estimated by Enzo...
07:00 , Mar 21, 2011 |  BioCentury  |  Finance

Fame is but a memory

Celera Corp. (NASDAQ:CRA), which was first to the finish line in the race to sequence the human genome, will be going out with a whimper barely a decade later when it is acquired by fellow...
07:00 , Apr 13, 2009 |  BC Week In Review  |  Company News

Celera management update

Celera Corp. (NASDAQ:CRA), Alameda, Calif.   Business: Genomics, Proteomics   Hired: Ugo DeBlasi as CFO, formerly chief accounting officer and VP and controller at Applera Corp. ; he replaces Joel Jung, who resigned  ...
07:00 , Aug 4, 2008 |  BC Week In Review  |  Company News

Celera board of directors update

Celera Corp. (NASDAQ:CRA), Alameda, Calif.   Business: Genomics, Proteomics   Appointed: Richard Ayers, retired chairman and CEO of The Stanley Works and former director of Applera Corp. ; Jean-Luc Belingard, president and CEO of Ipsen...
07:00 , Jul 7, 2008 |  BC Week In Review  |  Company News

Applera supply/service, genomics, proteomics news

Applera completed the previously announced spinout of its Celera Group, which is renamed Celera Corp. (NASDAQ:CRA, Rockville, Md.) (see BioCentury March, 10). Celera Corp. began trading July 1 on the NASDAQ under the symbol CRA...
07:00 , Mar 10, 2008 |  BC Week In Review  |  Company News

Applera supply/service, genomics, proteomics news

Last August, Applera retained Morgan Stanley to explore strategic alternatives for Celera and the Applied Biosystems operating group (see BioCentury, Aug. 13, 2007). Applera Corp. , Norwalk, Conn.   Business: Supply/Service, Genomics, Proteomics   Applera...
08:00 , Dec 24, 2007 |  BC Week In Review  |  Company News

Applied Biosystems management update

Applied Biosystems Group (ABI), Foster City, Calif.   Business: Supply/Service   Promoted: Mark Stevenson to president, COO and SVP of ABI's parent company Applera Corp. from EVP of ABI  ...
08:00 , Dec 24, 2007 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/21 cls Alkermes (ALKS) Banc of America Securities William Ho New Buy 8% $15.86 Ho set an $18 target. He believes exenatide LAR to...